drugset / Trial / NCT00323037

A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure

NCT00323037

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if Coreg CR is as effective as Coreg IR in improving heart function in subjects with stable chronic heart failure.

Timeline

Start
2006-03
Primary completion
2008-04
Completion
2008-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carvedilol Other / unclassified 3.125 mg Oral
Comparator Carvedilol Other / unclassified 6.25 mg Oral
Comparator Carvedilol Other / unclassified 10 mg Oral
Comparator Carvedilol Other / unclassified 12.5 mg Oral
Comparator Carvedilol Other / unclassified 20 mg Oral
Comparator Carvedilol Other / unclassified 25 mg Oral
Comparator Carvedilol Other / unclassified 40 mg Oral
Comparator Carvedilol Other / unclassified 80 mg Oral